Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)

Sue Lightman, Rachael Niederer, Srilakshmi Sharma, Claire Hooper, Oren Tomkins-Netzer*, Michal Kramer, Erika Marie Damato, Beatrice Peebo, Peter McCluskey

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e22-e24
Issue number3
StatePublished - Mar 2019

Cite this